Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Tan Chan, M.D.

Co-Author

This page shows the publications co-authored by Andrew Chan and Tracey Simon.
Connection Strength

7.424
  1. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma. Clin Liver Dis. 2020 11; 24(4):549-576.
    View in: PubMed
    Score: 0.891
  2. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020 06; 72(6):1062-1069.
    View in: PubMed
    Score: 0.854
  3. Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin-In Reply. JAMA Oncol. 2019 06 01; 5(6):911-912.
    View in: PubMed
    Score: 0.818
  4. Aspirin Use and the Risk of Cancer-In Reply. JAMA Oncol. 2019 06 01; 5(6):913.
    View in: PubMed
    Score: 0.818
  5. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma. JAMA Oncol. 2018 12 01; 4(12):1683-1690.
    View in: PubMed
    Score: 0.790
  6. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology. 2018 05; 67(5):1797-1806.
    View in: PubMed
    Score: 0.754
  7. Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis. Clin Nutr. 2022 02; 41(2):356-364.
    View in: PubMed
    Score: 0.244
  8. Adiposity, Adulthood Weight Change, and Risk of Incident Hepatocellular Carcinoma. Cancer Prev Res (Phila). 2021 10; 14(10):945-954.
    View in: PubMed
    Score: 0.237
  9. Microbiome Biomarkers: One Step Closer in NAFLD Cirrhosis. Hepatology. 2021 05; 73(5):2063-2066.
    View in: PubMed
    Score: 0.233
  10. Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women. Metabolism. 2020 12; 113:154398.
    View in: PubMed
    Score: 0.225
  11. Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality. N Engl J Med. 2020 03 12; 382(11):1018-1028.
    View in: PubMed
    Score: 0.216
  12. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 12; 17(13):2776-2784.e4.
    View in: PubMed
    Score: 0.204
  13. MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatol Commun. 2017 Jul; 1(5):429-438.
    View in: PubMed
    Score: 0.178
  14. Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men. Int J Cancer. 2021 10 15; 149(8):1529-1535.
    View in: PubMed
    Score: 0.059
  15. Association of Inflammatory and Insulinemic Potential of Diet and Lifestyle with Risk of Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):789-796.
    View in: PubMed
    Score: 0.057
  16. Plant-Based and Animal-Based Low-Carbohydrate Diets and Risk of Hepatocellular Carcinoma Among US Men and Women. Hepatology. 2021 01; 73(1):175-185.
    View in: PubMed
    Score: 0.057
  17. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. Lancet Gastroenterol Hepatol. 2020 11; 5(11):986-995.
    View in: PubMed
    Score: 0.056
  18. Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women. Hepatology. 2020 08; 72(2):535-547.
    View in: PubMed
    Score: 0.055
  19. Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank. Br J Cancer. 2020 07; 123(2):316-324.
    View in: PubMed
    Score: 0.055
  20. Physical Activity and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Cancer Prev Res (Phila). 2020 08; 13(8):707-714.
    View in: PubMed
    Score: 0.054
  21. High Dietary Intake of Vegetable or Polyunsaturated Fats Is Associated With Reduced Risk of Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 11; 18(12):2775-2783.e11.
    View in: PubMed
    Score: 0.053
  22. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. Int J Cancer. 2020 08 01; 147(3):675-685.
    View in: PubMed
    Score: 0.053
  23. Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women. Am J Gastroenterol. 2019 12; 114(12):1870-1877.
    View in: PubMed
    Score: 0.053
  24. Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men. Int J Epidemiol. 2019 12 01; 48(6):1863-1871.
    View in: PubMed
    Score: 0.053
  25. Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies. J Natl Cancer Inst. 2019 12 01; 111(12):1263-1278.
    View in: PubMed
    Score: 0.053
  26. Dietary Fat Intake and Risk of Hepatocellular Carcinoma in Two Large Prospective Cohort Studies (FS13-07-19). Curr Dev Nutr. 2019 Jun; 3(Suppl 1).
    View in: PubMed
    Score: 0.051
  27. A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women. Int J Cancer. 2020 03 01; 146(5):1241-1249.
    View in: PubMed
    Score: 0.051
  28. Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults. JAMA Oncol. 2019 Jun 01; 5(6):879-886.
    View in: PubMed
    Score: 0.051
  29. Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project. Cancer Res. 2019 08 01; 79(15):3973-3982.
    View in: PubMed
    Score: 0.051
  30. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prev Res (Phila). 2019 06; 12(6):367-374.
    View in: PubMed
    Score: 0.051
  31. Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Hepatology. 2019 08; 70(2):577-586.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.